Visual loss treated with osimertinib: A case report

被引：0

作者：

Drekolias, Dimitrios ^{[1
]}

Walter, Scott D. ^{[2
,3
]}

Alekshun, Todd ^{[4
]}

机构：

[1] Univ Connecticut, Hlth Ctr, Dept Internal Med, Farmington, CT 06032 USA

[2] Retina Consultants PC, Hartford, CT USA

[3] Hartford Hosp, Dept Ophthalmol, Hartford, CT USA

[4] Hartford HealthCare Canc Inst, Hartford, CT USA

来源：

CURRENT PROBLEMS IN CANCER: CASE REPORTS | 2022年 / 5卷

关键词：

Non-small cell lung cancer; Choroidal metastasis; Osimertinib; Tyrosine kinase inhibitor; CHOROIDAL METASTASES; CANCER;

D O I：

10.1016/j.cpccr.2022.100137

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Visual loss secondary to choroidal metastases is a rare initial presentation of lung cancer. Osimertinib is a third generation TKI used in treating advanced EGFR-mutation positive lung cancer. We present, to the best of our knowledge, the second published case of an EGFR-mutation positive non-small cell lung cancer (NSCLC) presenting as a choroidal metastasis and treated with osimertinib as first-line therapy.

引用

页数：3

共 9 条

[1] Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors [J].

Bouchez, Clementine ;

Pluvy, Johan ;

Soussi, Ghassen ;

Nguenang, Marina ;

Brosseau, Solenn ;

Tourne, Morgan ;

Collin, Megane ;

Theou-Anton, Nathalie ;

Guyard, Alice ;

Ammar, Jamila ;

Khalil, Antoine ;

Zalcman, Gerard ;

Gounant, Valerie .

BMC CANCER, 2020, 20 (01)

[2] Emerging Treatments for Choroidal Metastases [J].

Chen, Connie J. ;

McCoy, Allison N. ;

Brahmer, Julie ;

Handa, James T. .

SURVEY OF OPHTHALMOLOGY, 2011, 56 (06) :511-521

[3]

Ciardiello F, 2001, CLIN CANCER RES, V7, P2958

[4]

Dall'Olio Filippo Gustavo, 2017, J Thorac Oncol, V12, pe165, DOI 10.1016/j.jtho.2017.06.001

[5] Management of metastatic carcinoma of the uveal tract: an evidence-based analysis [J].

Kanthan, Gowri L. ;

Jayamohan, Jay ;

Yip, Desmond ;

Conway, R. Max .

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 35 (06) :553-565

[6] Treating Choroidal Metastases and Improving Vision with Osimertinib in EGFR T790M-Mutated Lung Adenocarcinoma: A Case Report and Review of the Literature [J].

Keshwani, Karim ;

Roelofs, Kelsey A. ;

Hay, Gordon ;

Lewis, Rachel ;

Plowman, Nick .

OCULAR ONCOLOGY AND PATHOLOGY, 2021, 7 (01) :26-30

[7] Choroidal metastasis from non-small-cell lung cancer responsive to Osimertinib: a case report: Efficacy of a third-generation epidermal growth factor tyrosine kinase inhibitor [J].

Mariachiara, Morara ;

Celeste, Ruatta ;

Federico, Foschi ;

Nicole, Balducci ;

Antonio, Ciardella .

INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (06) :2669-2675

[8] Treatment of choice for patients with EGFR mutation-positive non-small cell lung carcinoma presenting with choroidal metastases: radiotherapy or TKIs? [J].

Maskell, David ;

Geropantas, Konstantinos ;

Kouroupis, Michael ;

Glenn, Andrew ;

Ajithkumar, Thankamma .

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2017, 52 (01) :E22-E25

[9] Combination of intravitreal bevacizumab and systemic therapy for choroidal metastases from lung cancer: report of two cases and a systematic review of literature [J].

Maturu, Venkata Nagarjuna ;

Singh, Navneet ;

Bansal, Pooja ;

Mittal, Bhagwant Rai ;

Gupta, Nalini ;

Behera, Digambar ;

Gupta, Amod .

MEDICAL ONCOLOGY, 2014, 31 (04)

← 1 →